ORI
BHVN

Oak Ridge Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Oak Ridge Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,884
Closed -$3.01M – 163
2022
Q3 		$3.01M Sell
19,884
-65
-0.3% -$9.63K 0.46% 75
2022
Q2 		$2.91M Sell
19,949
-1,095
-5% -$140K 0.42% 76
2022
Q1 		$2.5M Sell
21,044
-12,351
-37% -$1.54M 0.28% 94
2021
Q4 		$4.6M Sell
33,395
-570
-2% -$72.5K 0.39% 81
2021
Q3 		$4.72M Sell
33,965
-1,263
-4% -$158K 0.42% 81
2021
Q2 		$3.42M Sell
35,228
-2,562
-7% -$208K 0.3% 104
2021
Q1 		$2.58M Sell
37,790
-480
-1% -$38.8K 0.24% 110
2020
Q4 		$3.28M Sell
38,270
-8,871
-19% -$752K 0.29% 108
2020
Q3 		$3.06M Buy
+47,141
New +$3.09M 0.24% 111

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Oak Ridge Investments's BHVN Position: Q4 2022 in Review

Oak Ridge Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 19,884 shares — an estimated $3.01M sold.

Oak Ridge Investments first reported a position in BHVN in Q3 2020 and held it in 9 quarters. The position peaked at $4.72M in Q3 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Oak Ridge Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Oak Ridge Investments sold 19,884 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $3.01M.
  • Oak Ridge Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2020 and held it in 9 quarters.
  • Oak Ridge Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $4.72M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Oak Ridge Investments's 13F filing for Q4 2022, filed 24 Jan 2023.